Pharm Tech Minutes 2021.09.02

From IHE Wiki
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.


Meeting Venue

Chania General Hospital "St. George"
Agiou Eleftheriou 28
73300 Mournies
Chania, Crete

The time slots mentioned in the schedule are the local time slots ( Greece). For Central Europe substract 1 hour For West Europe substract 2 hours

9:30 Start

  • Attendees
    • Juergen Brandstaetter
    • Trudy Hagg
    • Stephane Spahni
    • Jacqueline Surugue
    • Leonidas Tzimis
    • Michael Tan
  • On-line
    • Jose Costa Teixeira
    • Joao Almeida
    • Marc Robberecht
    • Richard de Jong ( Vaccination topic)
    • Onno Gieling ( Vaccination topic)
    • Roeland Luykx ( Vaccination topic)
  • Review minutes and action items

9:45 New work Items

  • Prescription FHIR profiles( see proposals Jose)
    • Project lead: Jose
    • Stakeholders: Belgium, Switzerland
  • Dispense FHIR profiles( see proposal Jose)
    • These 2 proposals will be combined as one work item
    • Project lead: Jose
  • Medication record (less urgent than the previous work item)
    • Project lead Jose
    • Stakeholder: Belgium?
  • Oncology medication management
    • A functional requirement is required. Preferably supported by a standard like IHE.
    • Candidate work item depending on funding
    • Project lead Juergen
    • Stakeholder: Vinzenz Gruppe Hospital Trust, Austria
  • Vaccination
    • Candidate work item depending on funding
    • Project lead Juergen
    • Stakeholder: Netherlands, Switzerland, WHO
    • other partners: PATH, US CDC, Gavi
  • Supply
    • Project lead Jose
    • Stakeholder: PATH, Digital Square, GS1
  • Motion to approve the list of work items
    • Vote: Abstain 0, Opposing 0, Approve 7

10:40 - 12:00 Work on work items (prescription/dispense)

  • Methodology:
    • Volume 1
      • Start flow with defining the use cases
      • define the actors
      • derive transactions of the use cases
      • Logical data models for the transactions
    • Volume 2:
      • technical specifications for transactions and actors.
      • examples for validation
  • Use cases:
    • include community and institutional setting
    • Controlled drugs: (Narcotics)?
    • Medical devices and health apps are currently not considered to be in scope.
    • Seek aligment with Unicom, eHDSI
  • The set of profiles should be equivalent to the CDA profiles which already exists.
  • Extension could happen.
  • What is the product: A FHIR copy of the CDA prescription?
  • Switzerland is using a FHIR based document
  • European projects ( e-Prescription) also FHIR based that work the same way as documents.
  • Other countries might not have the problem of existing legacy systems and may choose a full FHIR infrastructure.
  • IHE Pharmacy should provide solutions for both worlds. ( XDS infrastructure or RESTFUL based).
  • These 2 worlds will not be mixed. It is too complex to have a hybrid situation that would work in a mixed XDS and RESTDUL world.
  • The intermediate step is actually already filled in by Switzerland ( Oliver Egger). There is no requirement to make a IHE profile. It is only mapping.
  • Should focus on the FHIR based solution.
  • First should define agnostic logical models.
  • The implementation phase will set the direction for the method of communication.
  • Revisit the existing logical model and redo and write an implementation guide that could be used for CDA and FHIR configuration.

12:00-13:00 Lunch

13:00- 13:30 Visit Vaccination center

13:30- 16:00 Vaccination topic

  • Presentation by Juergen to get all participants aligned on the same wave length
  • Goal is global blueprint taking all varieties into consideration.
  • Basic need is to write and read a vaccination.
  • A second step could be the signalling a pending administration.
  • IHE will do a lot of footwork to organize meetings and provide content.
  • Coordination is necessary to manage the project.
  • WHO has a project called smart guidelines. Vaccination could be one of the guidelines.
  • Our project is complementary to these smart guidelines.
  • Switzerland has had a project on vaccination. The experience from this project could be of benefit of the IHE project.
  • Steps to achieve in the coming period:
    • Organize a workshop with the possible stakeholders.
    • Is it useful to consider comparing the input that is already available to use for planning purposes and explain the difference?
    • What is the scope of the vaccination project? Version 1 should contain the basic and minimal set.
      • administration registration
      • reporting of vaccination. This not immunization
    • Next stages could be:
      • planning of pending vaccination
      • adverse event registration

15:30- 16:00 Break

16:00- 17:30 Open

18:00 Adjourn